|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
RS56593B1
(sr)
|
2012-02-15 |
2018-02-28 |
Novo Nordisk As |
Antitela koja vezuju i blokiraju aktivirajući receptor eksprimiran na mijeloidnim ćelijama-1 (trem-1)
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
ES2690786T3
(es)
|
2012-02-15 |
2018-11-22 |
Novo Nordisk A/S |
Anticuerpos que se unen a la proteína 1 de reconocimiento de peptidoglicano
|
|
WO2014182927A1
(en)
*
|
2013-05-08 |
2014-11-13 |
Rutgers, The State University Of New Jersey |
Near infrared label and methods of use thereof
|
|
US9700638B2
(en)
|
2012-05-08 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Near infrared label and methods of use thereof
|
|
ES2874493T3
(es)
*
|
2013-02-08 |
2021-11-05 |
Novartis Ag |
Sitios específicos para modificar anticuerpos para generar inmunoconjugados
|
|
BR112015025549A2
(pt)
*
|
2013-04-07 |
2017-10-10 |
Bioex Therapeutics Inc |
anticorpo contra o receptor do fator de crescimento epidérmico
|
|
SI2991683T1
(sl)
|
2013-05-02 |
2020-01-31 |
Glykos Finland Oy |
Konjugati glikoproteina ali glikana s toksično obremenitvijo
|
|
CN105848671B
(zh)
|
2013-08-28 |
2019-12-13 |
艾伯维施特姆森特克斯有限责任公司 |
位点特异性抗体缀合方法和组合物
|
|
WO2015048312A1
(en)
|
2013-09-26 |
2015-04-02 |
Costim Pharmaceuticals Inc. |
Methods for treating hematologic cancers
|
|
MX2016005763A
(es)
|
2013-11-06 |
2016-08-19 |
Stemcentrx Inc |
Anticuerpos anti-claudina novedosos y metodos de uso.
|
|
WO2015089449A2
(en)
|
2013-12-12 |
2015-06-18 |
Stem Centrx, Inc. |
Novel anti-dpep3 antibodies and methods of use
|
|
JOP20200094A1
(ar)
|
2014-01-24 |
2017-06-16 |
Dana Farber Cancer Inst Inc |
جزيئات جسم مضاد لـ pd-1 واستخداماتها
|
|
KR20250162923A
(ko)
|
2014-01-31 |
2025-11-19 |
다이이찌 산쿄 가부시키가이샤 |
항-her2 항체-약물 접합체
|
|
JOP20200096A1
(ar)
|
2014-01-31 |
2017-06-16 |
Children’S Medical Center Corp |
جزيئات جسم مضاد لـ tim-3 واستخداماتها
|
|
KR20230088389A
(ko)
|
2014-02-11 |
2023-06-19 |
씨젠 인크. |
단백질의 선택적 환원
|
|
MX2016010677A
(es)
|
2014-02-21 |
2017-04-10 |
Abbvie Stemcentrx Llc |
Conjugados de anticuerpos anti-drosophila similar a delta 3 (anti-dll3) y medicamentos para usarse en el tratamiento contra melanoma.
|
|
KR20240110004A
(ko)
|
2014-03-14 |
2024-07-12 |
노파르티스 아게 |
Lag-3에 대한 항체 분자 및 그의 용도
|
|
RS66383B1
(sr)
*
|
2014-04-10 |
2025-02-28 |
Daiichi Sankyo Co Ltd |
Postupak za proizvodnju konjugata anti-her3 antitelo-lek
|
|
AU2015289054B2
(en)
|
2014-07-17 |
2021-04-08 |
Novo Nordisk A/S |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
EP3191127A1
(en)
|
2014-09-13 |
2017-07-19 |
Novartis AG |
Combination therapies of egfr inhibitors
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
US20160251417A1
(en)
*
|
2015-01-22 |
2016-09-01 |
Prothena Biosciences Limited |
Antibodies recognizing medin
|
|
GB201506407D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506389D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506399D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506393D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506394D0
(en)
*
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
ES2938186T3
(es)
|
2015-06-29 |
2023-04-05 |
Daiichi Sankyo Co Ltd |
Procedimiento de fabricación selectiva de un conjugado anticuerpo-fármaco
|
|
EP3484518B1
(en)
|
2016-07-07 |
2024-08-14 |
The Board of Trustees of the Leland Stanford Junior University |
Antibody adjuvant conjugates
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
KR102784846B1
(ko)
|
2016-12-12 |
2025-03-21 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트와 면역 체크 포인트 저해제의 조합
|
|
CA3050668C
(en)
|
2017-01-17 |
2023-08-15 |
Daiichi Sankyo Company, Limited |
Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
KR102322530B1
(ko)
*
|
2017-02-08 |
2021-11-05 |
화이자 인코포레이티드 |
캡핑된 및 비-캡핑된 항체 시스테인의 대규모 제조 공정 및 치료 단백질 접합에서의 그의 용도
|
|
CN117982673A
(zh)
|
2017-02-28 |
2024-05-07 |
第一三共株式会社 |
抗her3抗体-药物偶联物的应用
|
|
PL3612537T3
(pl)
|
2017-04-18 |
2022-11-07 |
Medimmune Limited |
Koniugaty pirolobenzodiazepin
|
|
MX2019012464A
(es)
|
2017-04-20 |
2019-12-11 |
Adc Therapeutics Sa |
Terapia combinada con un conjugado de anticuerpo y farmaco anti-axl.
|
|
TW202530271A
(zh)
|
2017-05-15 |
2025-08-01 |
日商第一三共股份有限公司 |
抗體－藥物結合物及其用途
|
|
UA127900C2
(uk)
|
2017-06-14 |
2024-02-07 |
Ейдісі Терапьютікс Са |
Схема дозування для введення adc до cd19
|
|
SI3668874T1
(sl)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pirolobenzodiazepinski konjugati
|
|
KR20250084239A
(ko)
|
2017-08-31 |
2025-06-10 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트의 개량 제조 방법
|
|
IL272964B2
(en)
|
2017-08-31 |
2024-02-01 |
Daiichi Sankyo Co Ltd |
Production method for antibody-drug conjugates
|
|
WO2019096788A1
(en)
|
2017-11-14 |
2019-05-23 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
JP7699927B2
(ja)
|
2018-04-02 |
2025-06-30 |
ブリストル－マイヤーズ スクイブ カンパニー |
抗ｔｒｅｍ－１抗体およびその使用
|
|
CN108642176B
(zh)
*
|
2018-04-12 |
2021-11-09 |
江门市中心医院 |
Part1作为乳腺癌诊断、治疗以及预后标志物的应用
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
TWI825098B
(zh)
|
2018-05-18 |
2023-12-11 |
德商葛萊高托普公司 |
抗ｍｕｃ１抗體
|
|
WO2019224340A1
(en)
|
2018-05-25 |
2019-11-28 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
CN112533958B
(zh)
|
2018-07-27 |
2024-11-15 |
第一三共株式会社 |
识别抗体-药物缀合物的药物部分的蛋白
|
|
AU2019315177A1
(en)
|
2018-07-31 |
2021-02-25 |
Daiichi Sankyo Company, Limited |
Treatment of metastatic brain tumor by administration of antibody-drug conjugate
|
|
CN112912109A
(zh)
|
2018-09-20 |
2021-06-04 |
第一三共株式会社 |
通过施用抗her3抗体-药物缀合物治疗her3-突变的癌症
|
|
EP3937984A1
(en)
|
2019-03-15 |
2022-01-19 |
Bolt Biotherapeutics, Inc. |
Immunoconjugates targeting her2
|
|
CA3130174A1
(en)
|
2019-03-15 |
2020-09-24 |
Medimmune Limited |
Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
|
|
CN110596387B
(zh)
*
|
2019-09-20 |
2020-06-12 |
四川大学华西医院 |
Cox10自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
|
|
GB202105186D0
(en)
|
2021-04-12 |
2021-05-26 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CN117285647A
(zh)
*
|
2022-06-17 |
2023-12-26 |
南京北恒生物科技有限公司 |
靶向ccr8的嵌合抗原受体及其用途
|